INmune Bio, Inc. (INMB) Tops Q3 EPS by 9c

INmune Bio, Inc. (NASDAQ: INMB) reported Q3 EPS of ($0.24), $0.09 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• Qatari Negotiators Are In Iran To Meet Iranian Officials In An Effort To De-escalate - Reuters
• INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC
• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance